American Urological Association - Malignant Peripheral Nerve Sheath Tumor
Home Education AUAUniversity Education Products & Resources Pathology for Urologists Retroperitoneum Malignant Peripheral Nerve Sheath Tumor

Malignant Peripheral Nerve Sheath Tumor

Image A

Image B

  • Diagnosis generally reserved for any spindle cell sarcoma arising from a nerve or neurofibroma, or showing nerve sheath differentiation.
  • At least half of MPNST's occur in patients with neurofibromatosis (although only 4-5% of NF-1 patients experience malignant transformation of their tumors).
  • Cytogenetic may shows complex structural and numerical chromosomal alteration and frequent loss of NF1 and p53.
  • Adults: 20's to 50's; men > women.
  • Usually associated with large nerve trunk so most common in the proximal portions of upper and lower extremities and trunk.
  • Gross: fusiform or eccentric swellings within a major nerve; may have secondary areas of hemorrhage or necrosis (image A).
  • Histology:
    • Majority are spindle cells (80%).
    • Nuclei are wavy or "comma-shaped."
    • Presence of mitotic activity within a neurofibroma is helpful criterion used in establishing a diagnosis of malignancy.
    • Other features supportive of malignancy: greater cellularity and nuclear pleomorphism (image B).
    • Less often may have epithelioid morphology.
    • A subset (15%) may show heterologous differentiation such as osteo- or chondrosarcoma, rhabdomyosarcoma, angiosaroma.
  • Immunohistochemistry: S-100 (+) (usually focal and not strong diffuse positivity seen in schwannoma).
  • Prognosis: Aggressive tumors with 5 year survival rate of 15-34%; high recurrence rate (>40%) and metastasis (up to 60%) commonly to the lung (mostly) and bone.